Filter
2291
Filtered Results: 2291
Text search:
clinical
trials
Featured
Recommendations
240
New Publications
396
Language
Document type
No document type
1162
Guidelines
435
Studies & Reports
382
Manuals
103
Fact sheets
84
Strategic & Response Plan
56
Training Material
28
Situation Updates
14
Resource Platforms
12
Infographics
11
Brochures
2
Videos
2
Countries / Regions
India
112
Global
95
South Africa
53
Kenya
39
Western and Central Europe
39
Africa
38
Uganda
25
East and Southern Africa
25
Latin America and the Carribbean
25
Ethiopia
24
West and Central Africa
24
Sierra Leone
22
Russia
22
Nigeria
20
Zambia
20
Brazil
20
Liberia
18
Nepal
18
Malawi
18
Tanzania
17
Ukraine
17
Eastern Europe
17
Rwanda
16
Philippines
15
Zimbabwe
14
Germany
14
Indonesia
14
Ghana
13
Middle East and North Africa
13
Bangladesh
11
Mozambique
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Asia
10
Guinea
9
South Sudan
8
Peru
8
USA
7
Cameroon
7
Eastern Europe and Central Asia
7
Burkina Faso
6
Eswatini/ Swaziland
6
Botswana
6
Angola
6
Lesotho
6
Cambodia
5
Colombia
5
Chile
5
Albania
5
Thailand
4
Sudan
4
North America
4
United Kingdom
4
Senegal
3
Guinea-Bissau
3
Haiti
3
Syria
3
China
3
Argentina
3
Paraguay
3
Vietnam
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Burundi
2
Myanmar / Burma
2
Sri Lanka
2
Laos
2
Tajikistan
2
Estonia
2
Georgia
2
France
2
Portugal
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Chad
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Other region
1
Southern Africa
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Jamaica
1
Denmark
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
562
Clinical Guidelines
353
Public Health
154
Women & Child Health
136
Key Resources
37
Pharmacy & Technologies
34
Capacity Building
21
Toolboxes
COVID-19
305
Mental Health
291
HIV
236
TB
187
NCDs
96
NTDs
94
AMR
72
Ebola
62
Pharmacy
59
Caregiver
57
Rapid Response
56
Disability
27
Planetary Health
24
Global Health Education
22
Refugee
18
Polio
13
Conflict
13
Cholera
11
Zika
11
Health Financing Toolbox
8
Natural Hazards
4
Social Ethics
4
Specific Hazards
2
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)...
May 5, 2022
The aim of this article is to identify the elements behind the country’s successful COVID-19 rollout as well as lessons and chal lenges derived from this process. The analysis is relevant to many countries today—as they keep searching for strategies to cope with the second year of the COVID-19 p...
Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122
Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Las infecciones del sitio quirúrgico (ISQ) constituyen una de las Infecciones Asociadas al Cuidado de la Salud (IACS) más frecuentes que ponen en riesgo a los pacientes llevando muchas veces al fracaso del procedimiento quirúrgico. Con una incidencia mucho mayor en países de medianos y bajos ing...
This document contains summary information on the latest projections from the IHME model on COVID-19 in Peru. The model was run on July 15, 2022, with data through July 10, 2022.
This document contains summary information on the latest projections from the IHME model on COVID-19
in Brazil. The model was run on July 15, 2022, with data through July 13, 2022.
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
